Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

81 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
General rules for recording endoscopic findings of esophagogastric varices (2nd edition).
Tajiri T, Yoshida H, Obara K, Onji M, Kage M, Kitano S, Kokudo N, Kokubu S, Sakaida I, Sata M, Tajiri H, Tsukada K, Nonami T, Hashizume M, Hirota S, Murashima N, Moriyasu F, Saigenji K, Makuuchi H, Oho K, Yoshida T, Suzuki H, Hasumi A, Okita K, Futagawa S, Idezuki Y. Tajiri T, et al. Among authors: murashima n. Dig Endosc. 2010 Jan;22(1):1-9. doi: 10.1111/j.1443-1661.2009.00929.x. Dig Endosc. 2010. PMID: 20078657
The skill qualification system for portal hypertension in Japan.
Ohta M, Murashima N, Ohyama T, Yoshida T, Hirota S, Kawanaka H, Hashizume M, Nakamura S, Chikamori F, Eguchi S, Tajiri T, Obara K, Kokubu S. Ohta M, et al. Among authors: murashima n. DEN Open. 2021 Nov 25;2(1):e74. doi: 10.1002/deo2.74. eCollection 2022 Apr. DEN Open. 2021. PMID: 35310701 Free PMC article.
Rifaximin-altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials.
Kawaguchi T, Suzuki F, Imamura M, Murashima N, Yanase M, Mine T, Fujisawa M, Sato I, Yoshiji H, Okita K, Suzuki K. Kawaguchi T, et al. Among authors: murashima n. Hepatol Res. 2019 Apr;49(4):404-418. doi: 10.1111/hepr.13300. Epub 2019 Feb 1. Hepatol Res. 2019. PMID: 30589492 Free PMC article.
Long-term interferon therapy for 1 year or longer reduces the hepatocellular carcinogenesis rate in patients with liver cirrhosis caused by hepatitis C virus: a pilot study.
Ikeda K, Saitoh S, Kobayashi M, Suzuki Y, Suzuki F, Tsubota A, Arase Y, Murashima N, Chayama K, Kumada H. Ikeda K, et al. Among authors: murashima n. J Gastroenterol Hepatol. 2001 Apr;16(4):406-15. doi: 10.1046/j.1440-1746.2001.02450.x. J Gastroenterol Hepatol. 2001. PMID: 11354279
81 results